Ottmann OG - Search Results

1

A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia.

Archimbaud E, Ottmann OG, Yin JA, Lechner K, Dombret H, Sanz MA, Heil G, Fenaux P, Brugger W, Barge A, O'Brien-Ewen C, Matcham J, Hoelzer D. Archimbaud E, et al. Among authors: ottmann og. Blood. 1999 Dec 1;94(11):3694-701. Blood. 1999. PMID: 10572081 Free article. Clinical Trial.

2

Treatment of myelodysplastic syndromes with cytokines and cytotoxic drugs.

Ganser A, Seipelt G, Eder M, Geissler G, Ottmann OG, Hess U, Hoelzer D. Ganser A, et al. Among authors: ottmann og. Semin Oncol. 1992 Apr;19(2 Suppl 4):95-101. Semin Oncol. 1992. PMID: 1372766 Review.

3

Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses.

Schardt C, Ottmann OG, Hoelzer D, Ganser A. Schardt C, et al. Among authors: ottmann og. Leukemia. 1992 May;6(5):370-4. Leukemia. 1992. PMID: 1375695

4

Interleukin-3 in the treatment of myelodysplastic syndromes.

Ganser A, Ottmann OG, Hoelzer D. Ganser A, et al. Among authors: ottmann og. Int J Clin Lab Res. 1992;22(3):125-8. doi: 10.1007/BF02591411. Int J Clin Lab Res. 1992. PMID: 1520908 Review.

5

In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells.

Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Falk S, Gillis S, Hoelzer D, Ganser A. Eder M, et al. Among authors: ottmann og. Blood. 1992 Jun 15;79(12):3274-84. Blood. 1992. PMID: 1596568 Free article.

6

Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.

Herrmann F, Mertelsmann R, Lindemann A, Ottmann OG, Seipelt G, Oster W, Hoelzer D, Ganser A. Herrmann F, et al. Among authors: ottmann og. Biotechnol Ther. 1991;2(3-4):299-311. Biotechnol Ther. 1991. PMID: 1845132 Clinical Trial.

7

Recombinant human interleukin-3 in patients with hematopoietic failure.

Ganser A, Lindemann A, Seipelt G, Ottmann OG, Eder M, Herrmann F, Frisch J, Schulz G, Mertelsmann R, Hoelzer D. Ganser A, et al. Among authors: ottmann og. Recent Results Cancer Res. 1991;121:162-72. doi: 10.1007/978-3-642-84138-5_18. Recent Results Cancer Res. 1991. PMID: 1857856 Clinical Trial.

8

Bone marrow findings after treatment with recombinant human interleukin-3.

Falk S, Seipelt G, Ganser A, Ottmann OG, Hoelzer D, Stutte HJ, Hübner K. Falk S, et al. Among authors: ottmann og. Am J Clin Pathol. 1991 Mar;95(3):355-62. doi: 10.1093/ajcp/95.3.355. Am J Clin Pathol. 1991. PMID: 1996545

9

Clinical effects of recombinant human interleukin-3.

Ganser A, Lindemann A, Seipelt G, Ottmann OG, Herrmann F, Eder M, Frisch J, Schulz G, Mertelsmann R, Hoelzer D. Ganser A, et al. Among authors: ottmann og. Am J Clin Oncol. 1991;14 Suppl 1:S51-63. doi: 10.1097/00000421-199112001-00010. Am J Clin Oncol. 1991. PMID: 2048566 Review.

10

Effect of recombinant human transforming growth factor beta and tumor necrosis factor alpha on bone marrow progenitor cells of HIV-infected persons.

Geissler RG, Ottmann OG, Eder M, Kojouharoff G, Hoelzer D, Ganser A. Geissler RG, et al. Among authors: ottmann og. Ann Hematol. 1991 May;62(5):151-5. doi: 10.1007/BF01703139. Ann Hematol. 1991. PMID: 2049459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters